Replimune Group Inc buy BMO Capital Markets
Start price
22.01.25
/
50%
€12.90
Target price
22.01.26
€25.92
Performance (%)
-48.84%
End price
23.01.26
€6.60
Summary
This prediction ended on 23.01.26 with a price of €6.60. Massive losses of -48.84% were the result for the BUY prediction by BMO_Capital_Markets. BMO_Capital_Markets has a follow-up prediction for Replimune Group Inc, but this time predicts that Replimune Group Inc is a Sell. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Replimune Group Inc | 0.775% | 0.775% | -17.197% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $18.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
In the thread Trading Replimune Group Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€2.40
23.07.25
23.07.25
€1.70
23.07.26
23.07.26
204.17%
02.04.26
02.04.26
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25